We hypothesize that detection of cryptic exon-encoded peptides in biofluids could reveal how early TDP-43 splicing repression is dysregulated in patients with ALS–FTD and could establish fluid biomarkers that reflect TDP-43 dysfunction (Extended Data Fig. 1). Here, TARDBP is linked to frontotemporal dementia.